Life Science Company News

Laryngeal Cancer Therapeutics Market size to grow by USD 575.25 million from 2022-2027| Accord Healthcare Ltd., Amgen Inc., AstraZeneca Plc, Athenex Inc. and more among the major companies in the market- Technavio

NEW YORK, Dec. 1, 2023 /PRNewswire/ -- The Laryngeal Cancer Therapeutics Market size is expected to grow by USD 575.25 million, accelerating at a CAGR of almost 5.43% during the forecast period, according to Technavio Research.  The report also includes detailed analyses of the competitive landscape of the market and information about major market companies, including Accord Healthcare Ltd., Amgen Inc., AstraZeneca Plc, Athenex Inc., Bayer AG, Bristol Myers Squibb Co., Celldex Therapeutics Inc., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Fresenius SE and Co. KGaA, Hangzhou Adlai Nortye Biopharma Co. Ltd., Hanmi Pharm Co. Ltd., Hikma Pharmaceuticals Plc, Merck and Co. Inc., Pfizer Inc., Regeneron Pharmaceuticals Inc., Sanofi, Sun Pharmaceutical Industries Ltd. and Teva Pharmaceutical Industries Ltd. This report offers an up-to-date analysis of the current market scenario, the latest trends and drivers, and the overall market environment. Read PDF Sample Report

Laryngeal Cancer Therapeutics Market: Company Profile:

Amgen Inc. - The company offers Vectibix R as a first-line treatment in patients with recurrent and metastatic squamous cell head and neck cancer.

•    To gain access to more vendor profiles available with Technavio, buy the report

Laryngeal Cancer Therapeutics Market: Segmentation Analysis

The market is segmented by Type (Biologics and Small molecules), Distribution Channel (Offline and Online), and Geography (North America, Europe, Asia, and Rest of World (ROW)).

The biologics segment is set to experience substantial growth in market share during the forecast period. Biologics, formulated from living organisms or their components, encompass monoclonal antibodies, recombinant proteins, tissues, and genes, widely employed in treating diverse oncology indications. These medicinal products often demonstrate high effectiveness with minimal or negligible adverse effects, owing to the remarkable stability associated with biologics.

Learn about the contribution of each segment summarized in concise infographics and thorough descriptions. View a PDF Sample Report

Laryngeal Cancer Therapeutics Market: Driver & Trend:

  • Increased growth in laryngeal cancer therapeutics market due to expanding reimbursement programs.
  • Governments worldwide acknowledge the importance of aiding cancer patients, specifically those with laryngeal cancer, through reimbursement schemes.
  • Improved patient access to advanced treatments with minimal effort due to these programs.
  • Reimbursement initiatives alleviate financial burdens on patients and incentivize pharmaceutical companies to invest in R&D, stimulating innovation in laryngeal cancer therapies.

Trend - The increasing prevalence of precision medicine is a key trend in the laryngeal cancer therapeutics market.

Identify key trends, drivers, and challenges in the market. Download the sample report to gain access to this information

Related Reports:

Breast Cancer Therapeutics Market: The breast cancer therapeutics market size is estimated to grow at a CAGR of 8.23% between 2022 and 2027. The market size is forecast to increase by USD 13,027.39 million.

Fallopian Tube Cancer Therapeutics Market: The fallopian tube cancer therapeutics market size is estimated to grow by USD 832.01 million at a CAGR of 10.35% between 2023 and 2028.

What are the key data covered in this laryngeal cancer therapeutics market report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the laryngeal cancer therapeutics market between 2022 and 2027.
  • Precise estimation of the laryngeal cancer therapeutics market size and its contribution to the market in focus on the parent market
  • Accurate predictions about upcoming trends and changes in consumer behavior
  • A thorough analysis of the market's competitive landscape and detailed information about vendors
  • Comprehensive analysis of factors that will challenge the growth of laryngeal cancer therapeutics market vendors.

TOC:

  1. Executive Summary
  2. Market Landscape
  3. Market Sizing
  4. Historic Market Sizes
  5. Five Forces Analysis
  6. Market Segmentation by Type
  7. Market Segmentation by Distribution Channel
  8. Market Segmentation by Geography
  9. Customer Landscape
  10. Geographic Landscape
  11. Drivers, Challenges, & Trendss
  12. Company Landscape
  13. Company Analysis
  14. Appendix

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research

Jesse Maida

Media & Marketing Executive

US: +1 844 364 1100

UK: +44 203 893 3200

Email: media@technavio.com

Website: www.technavio.com/

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/laryngeal-cancer-therapeutics-market-size-to-grow-by-usd-575-25-million-from-2022-2027-accord-healthcare-ltd-amgen-inc-astrazeneca-plc-athenex-inc-and-more-among-the-major-companies-in-the-market--technavio-302002789.html

SOURCE Technavio

By: PR Newswire Association LLC. - 01 Dec 2023
Back to overview

Enhance your business development with Biotechgate